# Editorial: Tailored strategies for lung cancer diagnosis and treatment in special populations

**Authors:** Run-Qi Guo, Natsuo Tomita, Chuan Li, Xin Nie

PMC · DOI: 10.3389/fmed.2026.1782836 · Frontiers in Medicine · 2026-02-12

## Full-text entities

- **Genes:** ALK (ALK receptor tyrosine kinase) [NCBI Gene 238] {aka ALK1, CD246, NBLST3}, CD274 (CD274 molecule) [NCBI Gene 29126] {aka ADMIO5, B7-H, B7H1, PD-L1, PDCD1L1, PDCD1LG1}, SMARCA4 (SWI/SNF related BAF chromatin remodeling complex subunit ATPase 4) [NCBI Gene 6597] {aka BAF190, BAF190A, BRG1, CSS4, MRD16, OTSC12}, EGFR (epidermal growth factor receptor) [NCBI Gene 1956] {aka ERBB, ERBB1, ERRP, HER1, NISBD2, NNCIS}, ERBB2 (erb-b2 receptor tyrosine kinase 2) [NCBI Gene 2064] {aka CD340, HER-2, HER-2/neu, HER2, MLN 19, MLN-19}
- **Diseases:** toxicity (MESH:D064420), metastases (MESH:D009362), constipation (MESH:D003248), lymph nodal metastasis (MESH:D008207), breast cancer (MESH:D001943), undifferentiated tumors (MESH:D002277), adenocarcinoma (MESH:D000230), tumor (MESH:D009369), Lung Cancer (MESH:D008175), SCLC (MESH:D018288), malignant pleural effusion (MESH:D016066), squamous cell carcinoma (MESH:D002294), NSCLC (MESH:D002289), lung adenocarcinoma (MESH:D000077192)
- **Chemicals:** pembrolizumab (MESH:C582435), cadonilimab (-), disitamab vedotin (MESH:C000722994)
- **Species:** Homo sapiens (human, species) [taxon 9606], Human immunodeficiency virus 1 (no rank) [taxon 11676]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12935593/full.md

---
Source: https://tomesphere.com/paper/PMC12935593